KDM4A-driven SMAD5/TGFβ axis activation as a therapeutic target in cholangiocarcinoma: mechanistic insights and translational implications
Qi Wang(Qingdao Agricultural University), Yongjun Chen(Tongji Hospital), Fei Xiong(Capital Medical University), Junsheng Chen(Nanfang Hospital), Bing Wang(Universidad del Noreste), Yiyang Kuai(Tongji Hospital), Wenzheng Liu(Tongji Hospital), Da Wang(Tongji Hospital), Guanhua Wu(Tongji Hospital)
Cited by 1
Related Papers
Gene body methylation in cancer: molecular mechanisms and clinical applications
|Clinical Epigenetics|2022|155
Advances in the DNA methylation hydroxylase TET1
|Biomarker Research|2021|71
SMAD Proteins in TGF-β Signalling Pathway in Cancer: Regulatory Mechanisms and Clinical Applications
|Diagnostics|2023|70
The emerging roles of CEACAM6 in human cancer (Review)
|International Journal of Oncology|2024|52